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Objectives: Objective of the present study was to translate and validate the 
Kidney Disease Quality of Life- Short form 1.2 (KDQOL-SFTM1.2) question-
naire in Hindi language for use in Indian Hindi speaking patients with kid-
ney stone. MethOds: Forward and backward translations were performed. 
Intermediate version of Hindi questionnaire was developed and was used for 
pilot study (n= 20). Modified final version after pilot study was used for vali-
dation study. Results: Questionnaire was administered to patients (n= 99) 
with kidney stone twice with an interval of four weeks. Cronbach alpha for total 
score was 0.71. For individual domains i.e. for the domain symptoms and kidney 
disease alpha value of 0.99 was gained, for the domain burden of kidney disease 
it was 0.79, for the domain effect of kidney disease on daily life it was 0.82, for 
the domain pain it was 0.99, for the domain physical functioning it was 0.91 and 
for the domain sexual function it was 0.99. No significant (p< 0.05) difference was 
observed in total score in test-retest analysis. cOnclusiOns: Translated Hindi 
Version of KDQOL-SFTM1.2 showed good internal consistancy, test-retest reliability 
and linguistic validity.
an outcome measure in interventional studies. Psychological distress is a subset of 
HRQoL that specifically evaluates the impact on mental health. In addition, social 
support and patients’ perception of illness have been shown to predict all-cause 
mortality in ESRD patients. However, local data comparing PRO and social support 
in hemodialysis (HD) vs. peritoneal dialysis (PD) patients are lacking. Hence, the 
objective of this cross-sectional, observational study was to evaluate and com-
pare patient-reported and laboratory outcomes in our multi-ethnic HD and PD 
patients. MethOds: Eligible chronic dialysis patients from National University 
Hospital were recruited. PRO measures include Kidney Disease Quality of Life-Short 
Form, EuroQoL-5 Dimensions and Kessler Psychological Distress Scale. Social sup-
port was assessed using Family Functioning Measure. Relevant sociodemographic 
information and medication list/laboratory parameters were captured using a pre-
tested health services utilization questionnaire, and clinic notes/electronic medical 
records respectively. All data were analysed and compared between HD and PD 
patients using Stata version 10. Results: A total of 113 patients were recruited (HD: 
n= 81, PD: n= 32). There were no significant differences in HRQoL, social support, 
level of distress and most laboratory parameters between HD and PD patients. 
However, HD patients had significantly higher serum albumin levels (38.2±3.6 g/L 
vs. 32.5±4.5 g/L, p< 0.001) while PD patients had significantly higher serum corrected 
calcium levels (2.41±0.2 mmol/L vs. 2.27±0.2 mmol/L, p= 0.004) and number of medi-
cations (10.1±3.1 vs. 8.8±2.9, p= 0.039). cOnclusiOns: Barring cost and patient-spe-
cific factors, HD and PD are likely equivalent therapeutic options for ESRD patients 
in Singapore. However, the findings need to be confirmed in a larger study.
